Full-Time
Associate Account Executive
Aae
LatchBio
11-50 employees
Cloud-based data platform for biotech R&D
Compensation Overview
$120k - $145k/yr
H1B Sponsorship Available
San Francisco, CA, USA
In Person
 Sales & Account Management (1) |
|---|
- 1 year experience as a Business Development Representative or Account Executive at an early-stage cloud or software company
- Background in biology — either in school or professionally
- Evidence of exceptional performance at your prior jobs
- Ability to understand and communicate technical concepts plainly
- Familiarity with Salesforce Customer Relationship Management and best practices
- Desire to excel at sales
- Refine ideal customer profile alongside product and sales team
- Orchestrate account-based marketing campaigns personalized to ICPs
- Write and refine messaging frequently based on outreach data
- Navigate and respond to leads to warm them up for qualification meetings
- Book demos and conduct hot-handoffs to our Account Executives to close opportunities
- Travel frequently to life sciences conferences around the world
Latch.bio provides a cloud-based data platform for biotech companies to manage and analyze their data. It stores unlimited raw data, organizes and transforms it, and offers analysis tools, all in one place. The platform also includes workflow orchestration, so teams can set up analyses that automatically run across many computing cores and scale as needed, while the interface makes it easy to view analysis results and make quick decisions. A key feature is a customizable data platform that eliminates the need for separate infrastructure setup and supports strong security for large-scale data processing. Compared with competitors, Latch.bio positions itself as a single, cost-efficient solution that replaces multiple tools and optimizes cloud usage to reduce expenses. Its goal is to help biotech companies move projects forward faster by making data analysis cheaper, simpler, and more accessible.
Company Size
11-50
Company Stage
Series A
Total Funding
$33M
Headquarters
San Francisco, California
Founded
2021
Simplify's Take
What believers are saying
- LatchBio hits $15M ARR with 5x QoQ growth, targeting $130M in 2026.
- Releases 25M cell spatial transcriptomics atlas across 45 tissues and 63 diseases.
- Launches GPU-accelerated nf-core/methylseq using Arioc aligner for faster processing.
What critics are saying
- Benchling captures 70% of top biotechs with LIMS integration, eroding LatchBio share in 12-24 months.
- Terra's free Google Cloud genomics platform diverts academic users in 6-12 months.
- NVIDIA BioNeMo accelerates pipelines 10x faster, obsoleting LatchBio infrastructure in 18-36 months.
What makes LatchBio unique
- LatchBio delivers no-code CRISPR workflows via web browser without cloud setup.
- Platform offers versioned bioinformatics tools and collaborative data visualization for biologists.
- Developers publish custom interfaces for phylogenetics, genome assembly, and CRISPR analysis.
Help us improve and share your feedback! Did you find this helpful?
Your Connections
People at LatchBio who can refer or advise you
Benefits
Competitive salary
Equity
Medical, dental, & vision insurance
Growth & Insights and Company News
6 month growth
↓ -17%1 year growth
↓ -20%2 year growth
↓ -17%LatchBio releases a 25M cell atlas for spatial transcriptomics, covering 45 tissue types, 63 diseases and 11 spatial technologies.
As a first case-study, LatchBio, Inc. is releasing an accelerated version of nf-core/methylseq that uses the GPU aligner Arioc developed by Richard Wilton.
Having already raised over US$28 million, LatchBio is making waves in the world of data management and clinical research; read on to learn more about the company's innovative solutions and how they are helping researchers overcome common bottlenecks!
LatchBio founders: Alfredo Andere, Kenny Workman, and Kyle Giffin. LatchBioMost industries today are experiencing an unprecedented data deluge – and synthetic biology is no exception. Twenty years ago, a typical biological experiment generated 3-5 megabytes of information. Today, a routine synthetic biology workflow produces anywhere from 1,000 to 40,000 terabytes. That is a billion times more data! Such a large number of data points is simply impossible to interpret by human eye. This is why almost every bio lab today has to set up custom bioinformatics pipelines, invest in cloud computing, and master advanced data visualization software – all that just to see the results of their experiments.A San Francisco startup, LatchBio, hopes to make data analysis much easier for biologists with its full-stack biocomputing infrastructure
Biologists and other scientists are confronted these days with a deep sea of data and a bewildering panoply of tools to apply to it — many of which require a specialist to operate. Hiring one is a challenge and farming out the work may take months … but LatchBio offers an option that can have []